A Concise Review of Current Radiopharmaceuticals in Tumor Angiogenesis Imaging

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|8|1032-1040

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.8, 2012-03, pp. : 1032-1040

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imaging of Tumor Angiogenesis: Current Approaches and Future Prospects

By  

Current Pharmaceutical Design, Vol. 12, Iss. 21, 2006-07 ,pp. : 2661-2672

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial Cell Targeted Molecular Imaging in Tumor Angiogenesis: Strategies and Current Status

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 7, 2013-10 ,pp. : 644-657

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Amino Acid-Based Radiopharmaceuticals for Tumor Imaging

By  

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 7, 2018-03 ,pp. : 561-583

Bentham Science Publishers

Access to resources Recommend Favorite

Imaging of Integrins as Biomarkers for Tumor Angiogenesis

By  

Current Pharmaceutical Design, Vol. 14, Iss. 28, 2008-10 ,pp. : 2943-2973

Bentham Science Publishers

Access to resources Recommend Favorite

Radiolabeled Tracers for Imaging of Tumor Angiogenesis and Evaluation of Anti-Angiogenic Therapies

By  

Current Pharmaceutical Design, Vol. 10, Iss. 13, 2004-05 ,pp. : 1439-1455

Bentham Science Publishers

Access to resources Recommend Favorite